Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Advancing Equity and Access to Care with the Association of Women in Rheumatology

Carina Stanton  |  August 11, 2025

The AWIR also invests in the ACR’s Advocacy Fund, which is used to support the expansion of RheumPAC’s donor base, expand participation in the ACR’s annual fly-in and more. “Overall,” Ms. Colton says, “the ACR and AWIR have a great collaborative partnership, and we look forward to continuing our work together.”

Making New Connections

Several specific ACR encounters at the AWIR meeting illustrate the importance and value of this collaboration. For one, Ms. Colton says, AWIR is a great venue to promote some lesser-known facets of ACR advocacy, such as monitoring emerging issues with private payers. “I was able to underscore the unique work of the ACR’s Insurance Subcommittee and the resources that we offer,” she says.

The ACR hosted a booth at the AWIR annual conference.

Direct connections with AWIR members were also a highlight for Ms. Colston at the meeting. One that stands out was a discussion with a fellow who is about to enter private practice in Seattle following completion of her program. She is excited to put down roots in her new place, including getting involved in advocacy both at the state and federal level. At the ACR booth, the fellow was able to sign up to receive action alerts and learn more about the ACR’s health policy priorities. “It is critical to meet advocates where they are to make integrating advocacy into their practice of medicine as easy as possible,” Ms. Colton stresses.

Time to connect with AWIR advocacy colleagues Dr. Melton and Dr. Ott was also a highlight of the meeting for Ms. Colton. “It was wonderful to provide an advocacy update alongside my advocacy colleagues, who have both volunteered their time with ACR committees,” she says, describing the joint education session as a great opportunity to demonstrate the work of the ACR’s advocacy team in action. Dr. Melton echoes this sentiment from the AWIR.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Looking Toward New Advocacy Goals

Through ongoing collaborative efforts being forged by the AWIR and the ACR, the next goals are to advance rheumatology training, care and legislation by enhancing rheumatology voices in every state and the nation.

One way Dr. Melton is help making this happen in the short term is by leading visits to Capitol Hill in Washington, D.C., in tandem with the ACR. Combined efforts help amplify shared priorities to lawmakers.

Another way AWIR members and the organization are advancing shared advocacy goals is through investing in RheumPAC, Dr. Melton adds. “RheumPAC is the only rheumatology-dedicated political action committee that champions our shared goals to stand together for excellence in rheumatic care for everyone.”

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & AdvocacyMeeting Reports Tagged with:Association of Women in Rheumatology (AWIR)

Related Articles

    Affiliate Society Council Active & Reenergized, Reports Chair Gwenesta B. Melton, MD

    September 21, 2024

    ASC Chair Gwenesta B. Melton, MD, shares the connections and activities that are helping the council develop stronger ties in and outside the ACR.

    Supporting Women in Rheumatology

    September 6, 2021

    In 2014, four rheumatologists formed a new organization to promote gender equity within the field. Today, the Association of Women in Rheumatology offers training and opportunities in leadership, business development, financial planning and more, as recently highlighted at its annual meeting Aug. 12–15.

    Gwenesta B. Melton, MD, Appointed New Chair of Affiliate Society Council

    March 10, 2024

    Gwenesta B. Melton, MD, wears many hats as a rheumatologist, teacher and champion for advocacy and collaboration. She has been involved with the ASC for more than a decade.

    AWIR & ACR: Building a Strong Future Rheumatology Community

    August 6, 2024

    The ACR was fortunate to participate in the Association for Women in Rheumatology’s 2024 Annual Meeting in Orlando. As this relationship grows every year, the AWIR and ACR are working together to build a sustainable and inclusive rheumatology community for the future.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences